AU · rank #16 · 2026-07-20
OR
PARIS · EUR · $232.47B (USD)
The exact numbers the algorithm saw.
| Composite score Z-score blend of all factors below. | 0.376 |
|---|---|
| EPS revisions (30d) Change in consensus EPS estimate over the past 30 days ($/share). | +$0.08 |
| Net revisions (30d) Number of analysts revising upward minus downward. | 5 |
| Insider signal (90d) | — |
| Analyst upside Consensus target $412.04 | +7.9% |
| Momentum acceleration 3-month minus 12-month momentum. | +10.94% |
| Analyst rating 5 = Strong Buy, 1 = Strong Sell. | 3.92 |
| Gross margin TTM | +74.3% |
| 52w high | $400.48 |
| Market cap (USD) | $232.47B |
The AI research card
Independent qualitative review of each pick before the order is placed. On the rare day the research service is unavailable, the paper book trades on the quant ranking alone and no card appears here.
Summary
L'Oréal is the world's largest cosmetics and beauty company, operating four divisions across mass, luxury, dermatological, and professional channels with €44 billion in 2025 sales.
Rationale
The analyst_upside_pct of 7.9% is backed by 21 analysts with 77.8% revision agreement and accelerating EPS upgrades across 7-, 30-, 60-, and 90-day windows, all anchored by a Q1 2026 beat that drove the stock's best single-day gain since 2008 — confirming the revision cycle is real and broadening.
Material risks
- 1Management explicitly flagged EUR 90–100m gross margin pressure from tariffs and oil costs in 1H 2026, directly threatening the EPS upgrade cycle that underpins this signal — a reversal in revisions would collapse the thesis quickly.
- 2Analyst target dispersion of 29.6% is unusually wide for a mega-cap defensive, suggesting meaningful disagreement on the magnitude of the recovery and leaving the 7.9% upside figure vulnerable to downward target revisions if the IT transformation disrupts H2 sales phasing.
AI verdict council
Each pick is reviewed independently by 3 models before any order. 3 of 3 voted to proceed.